background image
adjusted for any accrued and unpaid interest. The Notes are not redeemable prior to maturity except for specified
corporate transactions and events of default, and no sinking fund is provided for the Notes. The Notes do not
contain any financial covenants.
We separately account for the liability and equity components of the Notes. The carrying amount of the equity
component representing the conversion option is equal to the fair value of the Convertible Note Hedge, as
described below, which is a substantially identical instrument and was purchased on the same day as the Notes.
The carrying amount of the liability component was determined by deducting the fair value of the equity
component from the par value of the Notes as a whole, and represents the fair value of a similar liability that does
not have an associated convertible feature. A liability of $525 million as of the date of issuance was recognized
for the principal amount of the Notes representing the present value of the Notes' cash flows using a discount
rate of 4.54 percent. The excess of the principal amount of the liability component over its carrying amount is
amortized to interest expense over the term of the Notes using the effective interest method. The equity
component is not remeasured as long as it continues to meet the conditions for equity classification.
In accounting for $15 million of issuance costs related to the Notes issuance, we allocated $13 million to the
liability component and $2 million to the equity component. Debt issuance costs attributable to the liability
component are being amortized to expense over the term of the Notes, and issuance costs attributable to the
equity component were netted with the equity component in additional paid-in capital.
The carrying values of the liability and equity components of the Notes are reflected in our Consolidated Balance
Sheets as follows (in millions):
As of
March 31, 2013
As of
March 31, 2012
Principal amount of Notes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$633
$633
Unamortized discount of the liability component . . . . . . . . . . . . . . . . . . . . . . . . . .
(74)
(94)
Net carrying amount of Notes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$559
$539
Equity component, net . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$105
$105
As of March 31, 2013, the remaining life of the Notes is 3.3 years.
Convertible Note Hedge and Warrants Issuance
In July 2011, we entered into privately-negotiated convertible note hedge transactions (the "Convertible Note
Hedge") with certain counterparties to reduce the potential dilution with respect to our common stock upon
conversion of the Notes. The Convertible Note Hedge, subject to customary anti-dilution adjustments, provide us
with the option to acquire, on a net settlement basis, approximately 19.9 million shares of our common stock at a
strike price of $31.74, which corresponds to the conversion price of the Notes and is equal to the number of
shares of our common stock that notionally underlie the Notes. As of March 31, 2013, we have not purchased
any shares under the Convertible Note Hedge. We paid $107 million for the Convertible Note Hedge, which was
recorded as an equity transaction.
Separately, in July 2011 we also entered into privately-negotiated warrant transactions with the certain
counterparties whereby we sold to independent third parties warrants (the "Warrants") to acquire, subject to
customary anti-dilution adjustments that are substantially the same as the anti-dilution provisions contained in
the Notes, up to 19.9 million shares of our common stock (which is also equal to the number of shares of our
common stock that notionally underlie the Notes), with a strike price of $41.14. The Warrants could have a
dilutive effect with respect to our common stock to the extent that the market price per share of its common stock
exceeds $41.14 on or prior to the expiration date of the Warrants. We received proceeds of $65 million from the
sale of the Warrants.
92